A carregar...
Infliximab in the treatment of Crohn’s disease
The recent introduction of infliximab, a chimeric monoclonal antibody against tumor necrosis factor-α, has greatly modified the treatment of Crohn’s disease (CD). Data from the literature show encouraging results after intravenous infusion both for closure of intestinal or perianal fistulas and for...
Na minha lista:
Main Authors: | , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Dove Medical Press
2007
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1936311/ https://ncbi.nlm.nih.gov/pubmed/18360638 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|